logo
ProjectForthcoming

Decoding Neural Circuits in Cholangiocarcinoma

One of 10,000+ projects Taiyo tracks in Germany.

Source: EU Funding & Tenders Portal

Cholangiocarcinoma (CCA) is a highly aggressive and therapy refractory liver cancer with alarming mortality, representing ~2% of all cancer-related deaths globally. Incidence and mortality rates have been increasing in the past few decades, and 5-year overall survival rates are still only 7-20%, highlighting the urgent need for new therapies. A major therapeutic barrier in CCA is the complex tumou

Status
Prospective
Sector
Chemical (Industrial), Manufacturing (Industrial)
Location
Germany
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Decoding Neural Circuits in Cholangiocarcinoma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Decoding Neural Circuits in Cholangiocarcinoma” is an infrastructure initiative in the Chemical (Industrial) sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Cholangiocarcinoma (CCA) is a highly aggressive and therapy refractory liver cancer with alarming mortality, representing ~2% of all cancer-related deaths globally. Incidence and mortality rates have been increasing in the past few decades, and 5-year overall survival rates are still only 7-20%, highlighting the urgent need for new therapies. A major therapeutic barrier in CCA is the complex tumour microenvironment (TME), which shields tumour cells from effective immune responses. Recent studies have highlighted the role of nerve fibres in the TME and linked perineural invasion to cancer progression. However, the role of the nervous system in shaping the TME and how CCA may hijack neural signals for aggressive growth remains elusive. My central hypothesis is that a multi-omic, spatial map of the neuro-hepatic axis, coupled with causal circuit modulation, will expose druggable pathways and yield a clinically usable neural signature. Preliminary data from my group show that sympathetic fibre density predicts worse survival in CCA, sympathetic innervation is increased in two CCA mouse models, and chemical sympathectomy reduces tumour burden with a shift toward cytotoxic immunity. With LIVER-CIRCUITS I will (I) create the first spatial multi-omic atlas of neural-tumour-immune niches in human CCA by pairing in situ RNA profiling with high-plex protein imaging and joint embedding with a single-cell atlas. (II) Establish causality by tracing and modulating liver-innervating circuits using retrograde tracers and chemogenetics in preclinical models. (III) Finally, deliver translation via a neural biomarker panel, trained and tested unchanged in two independent cohort, and validate targets in human-derived in-vitro systems to enable pharmacologic intervention. My long-term vision for LIVER-CIRCUITS is to uncover fundamental mechanistic insights into nervous system-cancer interactions in CCA and translate these findings to new diagnostic tools and treatments.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Chemical (Industrial), Manufacturing (Industrial)

Article published date

2026-11-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project